Indication
Blepharospasm
Blepharospasm is a focal cranial dystonia characterized by involuntary, repetitive, or sustained contractions of the orbicularis oculi and associated periorbital muscles. Read more about Blepharospasm
5 drugs 4 manufacturers
Drugs that treat it
Common Blepharospasm therapies.
BOTOX COSMETIC (onabotulinumtoxinA)
XEOMIN (incobotulinumtoxinA)
XEOMIN (incobotulinumtoxinA)
BOTOX (onabotulinumtoxinA)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonBlepharospasm is a focal cranial dystonia characterized by involuntary, repetitive, or sustained contractions of the orbicularis oculi and associated periorbital muscles.
This neurological movement disorder predominantly affects middle-aged and older adults, with a notable female predominance.
Pathophysiologically, it involves impaired sensorimotor integration and loss of central inhibition within basal ganglia-thalamocortical and cerebellar circuits, often manifesting as an idiopathic condition known as benign essential blepharospasm or occurring secondary to local ocular irritation or central neurodegenerative pathology.
Clinically, it features progressive bilateral eyelid fluttering, excessive blinking, and forceful involuntary eye closure that can be exacerbated by stress or bright light, potentially culminating in functional blindness despite intact ocular visual pathways.
- nih.gov
Blepharospasm is a focal cranial dystonia characterized by involuntary, repetitive, or sustained contractions of the orbicularis oculi and associated periorbital muscles
- nih.gov
Blepharospasm is a focal cranial dystonia characterized by involuntary, repetitive, or sustained contractions of the orbicularis oculi and associated periorbital muscles This neurological movement disorder predominantly affects middle-aged and older adults, with a notable female predominance Pathophysiologically, it involves impaired sensorimotor integration and loss of central inhibition within basal ganglia-thalamocortical and cerebellar circuits, often manifesting as an idiopathic condition k...
- merckmanuals.com
Blepharospasm is a focal cranial dystonia characterized by involuntary, repetitive, or sustained contractions of the orbicularis oculi and associated periorbital muscles Pathophysiologically, it involves impaired sensorimotor integration and loss of central inhibition within basal ganglia-thalamocortical and cerebellar circuits, often manifesting as an idiopathic condition known as benign essential blepharospasm or occurring secondary to local ocular irritation or central neurodegenerative patho...
- nih.gov
This neurological movement disorder predominantly affects middle-aged and older adults, with a notable female predominance Clinically, it features progressive bilateral eyelid fluttering, excessive blinking, and forceful involuntary eye closure that can be exacerbated by stress or bright light, potentially culminating in functional blindness despite intact ocular visual pathways
- nih.gov
This neurological movement disorder predominantly affects middle-aged and older adults, with a notable female predominance
- medlineplus.gov
Pathophysiologically, it involves impaired sensorimotor integration and loss of central inhibition within basal ganglia-thalamocortical and cerebellar circuits, often manifesting as an idiopathic condition known as benign essential blepharospasm or occurring secondary to local ocular irritation or central neurodegenerative pathology
- nih.gov
Pathophysiologically, it involves impaired sensorimotor integration and loss of central inhibition within basal ganglia-thalamocortical and cerebellar circuits, often manifesting as an idiopathic condition known as benign essential blepharospasm or occurring secondary to local ocular irritation or central neurodegenerative pathology
Personalize your experience
Follow Blepharospasm and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.